Abstract
The predisposing genetic defect in multiple endocrine neoplasia type 1 has been assigned to chromosomal region 11q13. Our previous attempts to identify the MEN1 gene have resulted in the isolation of the phospholipase Cβ3 gene from the actual region. PLCB3 plays an important role in signal transduction and, moreover, shows loss of expression in some endocrine tumors, in accordance with a putative tumor suppressor gene function, and thus appears to be an excellent candidate for MEN1. We have therefore undertaken screening for constitutional mutations in individuals from MEN1 families. Several sequence alterations have been discovered, none of them however fulfilling the criteria for a disease-related mutation. We can now exclude PLCB3 from candidacy as the MEN1 gene.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 24 July 1996 / Revised: 16 August 1996
Rights and permissions
About this article
Cite this article
Weber, G., Grimmond, S., Lagercrantz, J. et al. Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1. Hum Genet 99, 130–132 (1996). https://doi.org/10.1007/s004390050326
Issue Date:
DOI: https://doi.org/10.1007/s004390050326